Authors


Helen Torok, MD

Latest:

Editorial Advisory Board Insights for Eczema Awareness Month: Helen Torok, MD

Helen Torok, MD, shares her atopic dermatitis insights.


Corinna S. Bowser, MD

Latest:

Sulfasalazine, dapsone: Good alternative options for treatment of chronic urticaria

Philadelphia - In patients with chronic urticaria who do not respond to standard antihistamine treatment, the older drugs sulfasalazine and dapsone represent promising new treatment alternatives, Lisa A. Beck, M.D. said here at the 2006 meeting of the American College of Allergy, Asthma & Immunology (ACAAI).


James Turner, M.D., Ph.D.

Latest:

Effectively managing GIF in the psoriasis patient

GIF typically manifests during the first six to 10 weeks of treatment, and affects existing plaques with or without the presence of new lesions.


Tim Troy

Latest:

Etanercept presents as quick Tx

National Report -- A study reported in a recent edition of the New England Journal of Medicine indicates people with moderate to severe plaque psoriasis treated with etanercept experienced significant clearing of skin lesions within the first two weeks of taking the medication.


Steven Emmet, M.D.

Latest:

Tech breakthroughs

Dial-up modems, which opened the Internet to a vast audience and are still commonly found in medical offices, nominally create a 56k connection, although it is often closer to 44k and, depending on your line quality, 28k. With the prodigious amount of spam and viruses being circulated these days, it can often take 30 minutes or more just to download an e-mail, and if my colleagues have sent large picture files, it could take 45 minutes or more.


Indra Neal Sinha

Latest:

Experimental therapy figures to save limbs

Cambridge, Mass. - An experimental therapy that makes use of fibroblast growth factor type 1 (FGF-1) encoded in naked plasmid DNA (NV1FGF) could save the limbs of patients afflicted with chronic wounds due to critical leg ischemia associated with peripheral arterial disease (PAD), according to Vincent Li, M.D., M.B.A.


John Kelly C.L.U., R.H.U.

Latest:

What's new in retirement planning?

Defined benefit pension plans as well as cash balance plans are generating a lot of interest with medical practices, both large and small.


David B. Mandell, J.D., M.B.A.

Latest:

Do You Have the Right Financial Adviser?

Experts detail 5 tips to ask a financial advisor so they can best serve your interests.


Christopher R. Jarvis, M.B.A.

Latest:

Four money-saving ideas can help you prepare for Tax Day 2010

As a physician, do you realize that, between income, capital gains, Medicare, self-employment and other taxes, you spend 40 percent to 50 percent of your working hours laboring for the IRS and your state?


Ilya Petrou M.D.

Latest:

New devices modify noninvasive skin tightening

Approximately 94 percent of patients treated with the multiple pass/low fluence algorithm showed visible skin tightening at the time of treatment.


David B. Mandell, JD, MBA

Latest:

Protecting Against Malpractice Liability: Insurance As Your First Line of Defense

David Mandell, JD, MBA, stated in the quest to protect against malpractice liability, insurance is certainly the first and most important line of defense.


Elizabeth W. Woodcock, MBA, FACMPE, CPC

Latest:

Reducing no-shows

Starting Oct. 1, 2007, the Centers for Medicare and Medicaid Services (CMS) officially endorsed the practice of physicians charging a fee to Medicare beneficiaries who fail to show up for appointments. If you charge Medicare patients a fee for missing appointments, however, you must charge the same fee to all who skip appointments, regardless of the payer.


Robert A. Ersek

Latest:

Surgeon shares rationale for lip on 12-year-old

The circumstances around this case are quite unusual, but the bottom line is that I had been called upon to justify my position of doing liposuction and an abdominoplasty on a youngster.


Michael Halloran, MBA, CFP

Latest:

Living in a Litigious World Demands Defensive Asset Protection

In today's society, the lawsuit is seen as a way to "get rich quick" rather than as a method of creating justice.


Karen Donley-Hayes

Latest:

Reaching for a retinoid? Less may be more

Washington - Adapalene 0.1 percent gel is similar in efficacy against acne, with fewer side effects, than either tazarotene 0.1 percent or a regimen in which patients were switched from one retinoid to the other after six weeks.


Lisa B. Samalonis

Latest:

Pediatric dermatoses: Off-label biologic use carries risks, benefits

Psoriasis in adults is among the most-researched inflammatory skin diseases. Yet treatment options for moderate-to-severe atopic dermatitis and psoriasis in children represents a largely unmet medical need, according to an expert.


Patty Reiman

Latest:

Light intensifier: LED combo treats rosacea erythema

Combining LED therapy with laser or intense pulsed light can effectively treat rosacea and subsequent erythema, an expert says.


Ilya Petrou, M.D.

Latest:

Study finds HS associated with acne conglobata

Hidradenitis suppurativa has come to be associated with systemic inflammation as well as a growing list of comorbidities including acne conglobate.


Lisa Samalonis

Latest:

Polycystic ovary syndrome treatment requires holistic approach

For young women with polycystic ovary syndrome (PCOS), dermatologists must diagnose the underlying hormonal issues to best treat the related skin symptoms, explains Helen M. Torok, M.D., medical director, Trillium Creek Dermatology & Surgery, Medina, Ohio.


Michelle Tackla

Latest:

Beautiful Minds?

Leading sources suggest that cosmetic surgeons should carefully monitor the psychological condition and ambitions of existing and potential cosmetic patients despite a recent study finding that aesthetic procedures significantly improve a patient's quality of life.


Mark G. Lebwohl, MD

Latest:

Key Takeaways For the Management of Plaque Psoriasis

Experts in dermatology share closing thoughts on the management of plaque psoriasis.


Steven Feldman, MD, PhD

Latest:

Long-term Safety and Tolerability Experience with TNF Inhibitors

The class of agents known as TNF inhibitors shares some common safety issues, but the safety profiles of specific agents vary due to differing characteristics and mechanisms. Comparing safety data of these drugs is, of course, complicated by differences in patient populations and experiences.


Alice B. Gottlieb, MD, PhD

Latest:

Alice Gottlieb, MD, PhD: Preventing Pain and Disability in Psoriatic Disease

Gottlieb reviews her lecture from the Society for Investigative Dermatology Annual Meeting.


Daniel N. Sauder, MD

Latest:

Immune Pathogenesis of Psoriasis: Role of Biologic Therapies

These are very exciting times for dermatology. Basic research is being applied to the development of new and more effective biologics to treat some of the most challenging conditions, psoriasis among them.


Bill Gillette

Latest:

Teledermatology helps patients help themselves

Teledermatology eases disease management for young acne patients.


John Otrompke

Latest:

A new look at lipolysis

Boston - Improvements on a non-invasive alternative to liposuction may revolutionize medical procedures in this area, according to a presentation at this year's International Master Course on Aging Skin.


Louise Gagnon

Latest:

Melanoma overlooked, has higher mortality in African-American patients

While the incidence of melanoma is lower among African-Americans than it is among Caucasians, mortality due to melanoma is higher among the former. The reason, experts say, is because skin cancers in African-Americans appear on sites where they behave more aggressively, and there is a delay in diagnosis with this patient population.


Jeanine Downie, M.D.

Latest:

Build practice revenues through physician-dispensed product sales

Inventory management can be a challenge. First and foremost, it's critical to work within your cost analysis and projections to purchase the amount of product that you can physically store and sell.


Joely Kaufman

Latest:

Lowdown on lasers

Power, energy and fluence ... are really just a few of the parameters of a laser.


Maury M. Breecher, Ph.D., M.P.H.

Latest:

The ArteFill advantage: Longevity

San Diego - ArteFill (Artes Medical), the latest federally approved facial filler, offers dermatologists a long lasting alternative, and, although it has come late to the party, it is the only product now approved that has a potential to remain in the face for years, experts say.

© 2024 MJH Life Sciences

All rights reserved.